Senior Radiopharma Clinical Lead — HCC/GI (Remote)

Regulatory Jobs; United States; Remote; USD 307,000 - 372,000; Full time

Benefits offered by this job

Health Coverage

Wellbeing Support

Financial Well-being and Protection

Job summary

RayzeBio, a Bristol Myers Squibb subsidiary, seeks a Clinical Development Lead to oversee IND-Phase 3 plans for radiopharmaceutical assets in HCC/GI cancers. You will drive cross-functional study teams, engage with health authorities, and mentor clinical scientists to advance patient-focused therapies in oncology.

Ideal candidates hold an MD with oncology subspecialty, 5+ years in pharma/biotech oncology development, and a proven ability to operate in a highly regulated environment with

Qualifications

• MD with sub-specialty in oncology and 5+ years pharma/biotech experience in oncology solid tumor clinical development.
• Expertise in HCC and/or GI cancers is required.

Responsibilities

• Interact with investigators and thought leaders to design a clinical development plan.
• Lead internal study teams and partner with investigators and CROs to design and implement clinical studies.
• Work with asset GPLs to optimize development and commercial aspects of RayzeBio assets.
• Contribute to writing protocols, investigator brochures, clinical study reports, and trial documents.
• Lead regulatory interactions and prepare briefing documents for health authority meetings.
• Oversee data review and monitoring committees and ensure compliant trials.
• Translate research findings into clinical development opportunities.
• Travel approximately 30% as needed.

Skills

Clinical development

Oncology trials

Regulatory interactions

Team leadership

Cross-functional collaboration

Medical writing oversight

Education

MD with oncology subspecialty

Job description

RayzeBio, a Bristol Myers Squibb subsidiary, seeks a Clinical Development Lead to oversee IND-Phase 3 plans for radiopharmaceutical assets in HCC/GI cancers. You will drive cross-functional study teams, engage with health authorities, and mentor clinical scientists to advance patient-focused therapies in oncology.

Ideal candidates hold an MD with oncology subspecialty, 5+ years in pharma/biotech oncology development, and a proven ability to operate in a highly regulated environment with